Related Experiment Video
Updated: Jul 9, 2026
Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
Primary breast diffuse large B-cell lymphoma mimicking breast carcinoma: a diagnostic challenge - case report
Yazan Soliman Khadour1, Khoder Mreabi1, Abdelhaleem Elmohazzem1
1Faculty of Medicine, Tartous University, Tartous, Syrian Arab Republic.
Introduction:
Primary breast lymphoma (PBL) is a rare malignancy that may clinically and radiologically mimic breast carcinoma. Accurate pathological diagnosis is essential to guide treatment and avoid unnecessary radical surgery.
Presentation Of Case:
A 47-year-old woman presented with a painless right breast mass and ipsilateral axillary lymphadenopathy. Initial core-needle histology was interpreted as grade 2 invasive ductal carcinoma, and the patient underwent right mastectomy with axillary dissection. Postoperative immunohistochemistry (IHC) showed tumor cells positive for CD20 and negative for cytokeratin and T-cell markers, consistent with primary breast diffuse large B-cell lymphoma (PB-DLBCL). The patient received six cycles of R-CHOP and remains in complete remission at a 2-year follow-up.
Discussion:
PBL may be morphologically indistinguishable from carcinoma on limited H&E sections. Therefore, IHC is essential to differentiate lymphoma from epithelial malignancy; when feasible, adequate preoperative sampling and targeted immunostains should be considered to prevent unnecessary mastectomy. R-CHOP chemotherapy is the mainstay of treatment for PB-DLBCL.
Conclusion:
Consider PBL in the differential diagnosis of breast masses. Adequate sampling and IHC are crucial to directing appropriate, non-surgical therapy.
